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a b s t r a c t
Ozone (O3) is a serious public health concern. Recent ﬁndings indicate that the damaging health effects of
O3 extend to multiple systemic organ systems. Herein, we hypothesize that O3 inhalation will cause
downstream alterations to the liver. To test this, male Sprague-Dawley rats were exposed to 0.5 ppm O3
for 8 h/day for 5 days. Plasma liver enzyme measurements showed that 5 day O3 exposure did not cause
liver cell death. Proteomic and mass spectrometry analysis identiﬁed 10 proteins in the liver that were
signiﬁcantly altered in abundance following short-term O3 exposure and these included several stress
responsive proteins. Glucose-regulated protein 78 and protein disulﬁde isomerase increased, whereas
glutathione S-transferase M1 was signiﬁcantly decreased by O3 inhalation. In contrast, no signiﬁcant
changes were detected for the stress response protein heme oxygenase-1 or cytochrome P450 2E1 and
2B in liver of O3 exposed rats compared to controls. In summary, these results show that an
environmentally-relevant exposure to inhaled O3 can alter the expression of select proteins in the liver.
We propose that O3 inhalation may represent an important unrecognized factor that can modulate
hepatic metabolic functions.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Approximately 50% of the U.S. population resides in areas where
ambient ozone (O3) concentrations exceed the current 0.075 ppm
8 h time average set by the National Ambient Air Quality Standards
(NAAQS) [1]. O3 is a primary component of photochemical smog
and is a serious public health concern especially when air quality is
poor. Persons particularly sensitive to O3 exposure include the
elderly, young children, and those with pre-existing pulmonary
diseases such as asthma and chronic obstructive pulmonary disease.
It is established that exposure to high levels of O3 decreases lung
function, increases pulmonary hyper-reactivity, causes airway
epithelial cell damage and remodeling, and increases epithelial
permeability [2–4].
In addition to adverse pulmonary effects, emerging evidence
shows that O3 inhalation can cause tissue injury and altered
metabolism in other systemic organ systems. For example, studies
in nonhuman primates show that postnatal episodic O3 exposure
only during infancy (30 days to 6 months of age) resulted in long-
term effects to the systemic innate immune system that were
detectable up to 1 yr of age [5]. Recent epidemiologic studies report
a positive correlation of air pollution exposure with increased
cardiovascular-related morbidity and mortality resulting in increased
hospital admissions related to cardiac events [6–9]. Additional
studies reported that successive days of high ambient O3 exposure
correlated with increased blood pressure, blood lipids, and decreased
glucose tolerance in humans [8]. Ballinger, Postlethwait, and collea-
gues showed that exposure to 0.5 ppm O3 induced vascular dysfunc-
tion and increased aortic mitochondrial DNA damage in healthy
wild-type mice, and increased progression of atherosclerosis in mice
genetically predisposed to cardiovascular disease [10]. Moreover,
a single 5-day regimen of O3 also increased mtDNA damage in the
abdominal aorta of infant nonhuman primates [10]; a model more
closely mimicking human exposures. This work is important because
not only does it provide direct evidence that O3 inhalation damages
the cardiovascular system, but also shows that O3 has the potential to
exacerbate cardiovascular disease including atherosclerosis [11].
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O3 inhalation has also been shown to induce metabolic changes
in other peripheral organ systems. For example, pentobarbital-
induced sleeping times increased after O3 exposure, suggesting
alterations in hepatic drug metabolism and clearance mechanisms
[12,13]. Since this early work, other groups have addressed the effect
of inhaled O3 on the liver. Last and colleagues, using a microarray
approach, examined the effects of O3 (1.0 ppm) on the liver tran-
scriptome and showed that O3 inhalation signiﬁcantly decreased the
mRNA levels of several xenobiotic, carbohydrate, and fatty acid
metabolism genes [14]. Other groups have shown that acute expo-
sures of O3 (1.0–2.0 ppm) for 3 h increased nitric oxide production in
isolated hepatocytes, as well as increased rates of protein synthesis
[15]. Herein, our goal was to determine whether inhalation of O3 at a
concentration lower than used in previous studies, alters the hepatic
proteome and speciﬁc xenobiotic metabolizing enzymes in an animal
model without pre-existing disease.
Materials and methods
O3 exposure protocol
Male Sprague-Dawley rats were purchased from Harlan Labora-
tories (Barrier 217 VAF, Indianapolis, IN) and were provided standard
rat chow and water ad libitum. Animals were housed two per cage
under barrier conditions and maintained using a standard 12 h light-
dark cycle. Rats were exposed to either ﬁltered air (FA) or ozone (O3) at
0.5 ppm for 8 h/day for 5 days between 9:00 AM to 5:00 PM in the
University of Alabama at Birmingham (UAB) Environmental Exposure
Facility. Standard laboratory rat chow was removed from cages before
the start of exposures to prevent rats from ingesting food that may
contain oxidized nutrients (e.g., lipids, thiols, antioxidants) as a
consequence of O3 reaction. Rat chow was also removed from cages
of FA exposed rats. Fresh food was returned to cages after exposures
and present throughout the entire dark period when rats are active
and consume food. The exposure protocol had no effect on body
weight (FA: 34874 g and O3: 341715 g, p¼0.69). Prior to exposures,
animals were acclimated to the chambers for at least 72 h before
beginning FA and O3 exposures to minimize stress associated with a
novel environment. Importantly, rats remained in their home cage
with bedding and water, with cages (stainless steel wire mesh cover-
ings) placed into the exposure chamber. O3 was generated from 100%
O2 using a model OZ1PCS-V/SWO3 generator (Ozotech Inc, Yreka, CA),
mixed with FA, and ﬂowed into 0.8 m3 stainless steel chambers
(22 1C, 50% relative humidity; 30 volume changes/hr). O3 concen-
trations were continuously monitored using a Thermo-Environmental
Model UV Photometric analyzer (Thermo-Environmental, Franklin,
MA). Measurements obtained inside the cages demonstrated that O3
concentrations in the animals breathing zones were equivalent to the
chamber bulk phase concentrations. FA controls were housed in
separate chambers receiving the same clean air supply at equal air
exchange rates throughout the duration of the exposure regimen.
Animals were anesthetized with a 50 mg/kg body weight (i.p.)
injection of sodium pentobarbital and euthanized via exsanguination.
Tissues were harvested within 1 h of cessation of the exposure.
All procedures were approved by the University of Alabama at
Birmingham Institutional Animal Care and Use Committee.
Bronchoalveolar lavage and cell differential analysis
A cannula was inserted into the trachea via a midline tracheot-
omy, the chest cavity opened via a midline thoracotomy, and 9 mL of
warmed (37 1C) phosphate buffered saline (pH 7.0; 310 mOsm) was
gently instilled and withdrawn 3 times to yield bronchoalveolar
lavage (BAL) [16]. The BAL was subjected to a standard cytospin
procedure (StatSpin Cytofuge, Norwood, MA) to determine cell
counts and types. Slides were stained with a modiﬁed Wright-
Giemsa stain and 300 cells (100 cells per lane) were counted under
a light microscope using characteristics unique to each cell type [17].
Total cell counts were averaged for each cell type and percent of total
cells calculated. The remaining BAL was centrifuged to generate BAL
ﬂuid (BALF) and protein concentrations in the BALF were measured
to determine whether altered epithelial permeability [18] was
detectable after the 5th period of O3.
Plasma chemistries for liver enzymes and histology
Blood was collected via the abdominal aorta using a heparin-
coated syringe and centrifuged at 4 1C at 2000g for 10 min to
obtain plasma. Alanine and aspartate aminotransferase (ALT and
AST, respectively) activities were measured in plasma using a
spectrophotometric assay per manufacturer's directions (Pointe
Scientiﬁc, Inc, Canton MI). Brieﬂy, NADþ oxidation was recorded
under constant temperature conditions (37 1C) over a time period
of 10 min at 340 nm. The rate was measured and ALT and AST
levels reported as international units/liter (IU/L). Liver tissue was
ﬁxed in formalin and parafﬁn embedded. Sections were mounted
on slides and stained with hematoxylin and eosin (H&E). Slides
were scored for injury, steatosis, and inﬂammation by a patholo-
gist blinded to the experimental groups.
Two dimension isoelectric focusing/SDS-PAGE (2D IEF/SDS-PAGE)
Livers were excised and homogenized in ice-cold 0.25 M sucrose,
5 mM Tris–HCl, and 1 mM EDTA, pH 7.4, containing protease
inhibitors [phenylmethylsulfonyl ﬂuoride (40 mg/mL), leupeptin
(5 mg/mL), and pepstatin A (7 mg/mL)] [19]. Protease inhibitors were
included to prevent sample degradation prior to proteomic analyses.
For proteomic studies there were six FA (control) and six O3 exposed
rats per group. Post-nuclear supernatant fraction was prepared by
centrifugation of liver homogenates at 568g for 10 min at 41C. Protein
concentrations were determined using the Bradford protein assay
and bovine serum albumin (BSA) as a standard [20]. Proteomic
analyses were performed by methods as previously described [21].
Post-nuclear supernatant (100 mg) from liver homogenates was
added to IEF gel strip rehydration buffer containing 7 M urea, 2 M
thiourea, 2% (w/v) CHAPS, 0.5% (w/v) n-dodecyl-ß-D-maltoside,
0.002% (w/v) bromophenol blue, ampholine electrophoresis reagent
(Sigma, St. Louis, MO, range pH 3–10), 0.04 M DTT and 2 mM
tributylphosphine. Following protein extraction, samples were
applied to IEF gel strips (Invitrogen ZOOM Strips, pH 3–10, Carlsbad,
CA) and rehydration of IEF strips was done overnight. For SDS-PAGE,
IEF gel strips were placed horizontally on top of a 10% resolving gel
with 4% stacking gel, and sealed into place using warm agarose
(1%, w/v) and gels were run at 100 V for 112 h. After electrophoresis,
gels were stained with Sypro Ruby™ (Invitrogen, Carlsbad, CA) for
total protein. Protein stained gels were imaged using a Bio-Rad
ChemiDoc XRS imaging system (Bio-Rad Laboratories, Inc,
Hercules, CA).
2D gel image analyses
Methods for gel analyses are described in our previous work
[21]. Differences in protein density were performed using PDQuest
Image Analysis software (Bio-Rad, Hercules, CA). Individual pro-
tein spots on all twelve 2D gels (n¼6 for FA and n¼6 for O3) were
identiﬁed using the program software and visually matched for
accuracy. A master gel was created to serve as the reference gel for
FA and O3 groups, which the PDQuest software program uses
automatically to match the spots across all gels. Manual veriﬁca-
tion was then used to correct for incorrect spot matching to the
reference gel or spots not initially detected by software. In order to
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correct for any differences in protein loading, the density for all
spots in each gel was normalized to total density in veriﬁed
protein spots for that particular gel. The protein densities were
then entered into a spreadsheet and statistically signiﬁcant differ-
ences were determined using an unpaired t-test (two-tail).
Protein identiﬁcation with matrix assisted laser desorption ionization
time of ﬂight (MALDI-TOF) mass spectrometry
Protein identiﬁcation was performed as previously described
[21]. Protein spots were cut from gels and processed using
standard methods in the UAB mass spectrometry shared facility
(http://www.uab.edu/proteomics). Brieﬂy, protein samples were
de-stained with three successive 30 min washes in 1:1 solution of
50 mM NH4HCO3 and acetonitrile. Samples were treated with
10 mM dithiothreitol in 50 mM NH4HCO3 for 60 min at 60 1C to
reduce cysteine residues, which was followed by alkylation of free
cysteines with 55 mM iodoacetamide in 50 mM NH4HCO3 for
60 min. This was followed by 16 h incubation at 37 1C with trypsin
to digest proteins. The resulting solution was extracted by two
successive 30 min washes in a 1:1 solution of 5% formic acid and
acetonitrile, supernatants were collected, and dried using a Savant
SpeedVac. Lyophilized samples were resuspended in 0.1% formic
acid, desalted (C18 ZipTips, Millipore), and diluted 1:10 with a
saturated solution of α-cyano-4-hydroxycinnamic acid matrix
before being applied to MALDI-TOF plates. Samples were analyzed
with a Voyager De-Pro mass spectrometer in the positive mode
and resulting spectra were analyzed using Voyager Explorer soft-
ware. Peptide masses were submitted to the Mascot database for
protein identiﬁcation (www.matrixscience.com). Mascot uses a
probability based system of the Mowse algorithm to determine
signiﬁcant results [22]. Mowse is an algorithmic calculation used
to assign statistical weight to each peptide match; thus, a higher
Mowse score implies higher statistical likelihood of the match
being correct. Herein, the Mascot results for proteins IDs ranged
from 132–467. All scores were440 indicating extensive homology
and signiﬁcant matches for this study (pr0.05).
Western blotting
Based on gene expression results from other studies [12–14] we
decided to examine the effect of inhaled O3 on select cytochrome
P450 (CYP450) enzymes and the stress-inducible enzyme heme
oxygenase 1 (HO-1) in the liver. Equal amounts of protein from
post-nuclear supernatant fractions (40 or 50 mg) were loaded and
separated on 12% SDS-PAGE gels then transferred for 1 h to
nitrocellulose membranes. Membranes were blocked overnight
in 5% (w/v) non-fat milk in Tris base saline solution with Tween-20
(TBS-T) while shaking at 5 1C. Levels of HO-1 protein were
detected using a 1:5,000 dilution of primary antibody (Stressgen,
Ann Arbor, MI). Levels of CYP2E1 and CYP2B were detected using
1:1,000 primary antibody dilutions (Chemicon International,
Temecula, CA). After successive washes in TBS-T, blots were
incubated in horseradish peroxidase (HRP) conjugated anti-
rabbit secondary antibody (1:10,000) in 5% (w/v) non-fat milk in
TBS-T for 1 h (Sigma, St. Louis, MO). Bands were visualized using
luminol-based chemiluminescence reagents with a ChemiDoc XRS
System (Bio-Rad, Hercules, CA) and quantiﬁcation of band densi-
ties were achieved using Quantity One software (Bio-Rad, Her-
cules, CA) [23]. To ensure equal protein loading of lanes, GAPDH
was used as a loading control at a dilution of 1:1000 anti-GAPDH
primary antibody. A representative example of a CYP2B blot
reprobed for GAPDH is shown in Fig. 2D. Further, equal protein
loading of gels was conﬁrmed using total protein staining (e.g.,
SYPROs Ruby protein gel stain: FA¼34,87574241 and O3¼
36,07973337 arbitrary density units; n¼6, p¼0.59) for blots
not reprobed with GAPDH.
Statistical analyses
Statistical signiﬁcance for all measured parameters was assessed
using an unpaired t-test and signiﬁcance was determined with a p
valuer0.05.
Results
Lung cell differential and BALF protein
BALF from FA and O3 exposed rats was assessed for epithelial
permeability and inﬂammatory cell inﬁltration as described in Meth-
ods. No signiﬁcant change in BALF protein concentration were
observed between FA and O3 exposed groups; 63.0727.9 and
72.9746.2 μg/mL, respectively (p40.05). Cell differential analysis also
revealed that macrophage, lymphocyte, neutrophil, or basophil air-
space populations in O3 exposed rats did not differ from FA controls at
the end of the 5 days of O3 exposure protocol (Table 1).
Effect of O3 exposure on plasma liver enzymes and histology
Plasma ALT and AST enzyme activities were measured as indica-
tors of hepatocellular damage due to O3 exposure. After 5 days of
0.5 ppm O3 exposure, AST enzyme activity levels for FA and O3
groups were 47.272.3 and 55.2713.2 IU/L, respectively. Similarly,
ALT enzymes activity levels for FA and O3 groups were 48.973.7 and
51.078.9 IU/L, respectively. No statistically signiﬁcant changes were
observed in liver enzyme activities in the O3 treated group compared
to the FA group (p40.05). Additionally H&E-stained liver sections
scored for changes to liver morphology, inﬂammation, and injury
showed no pathology and no differences between O3 and FA groups
(data not shown). These results demonstrate that this inhaled O3
exposure regimen did not cause detectable toxicity to the liver.
Effect of ozone exposure on liver proteome
Representative 2D IEF/SDS-PAGE gel images from both FA and O3
treatment groups are shown in Fig. 1. A global 2D proteomic
approach was performed to determine whether O3 inhalation
altered liver protein abundance. Following separation of proteins
in two dimensions (isoelectric point and molecular weight), pro-
teins were analyzed for differences in abundance using PDQuest
software tools as described in Methods. Using this mini-gel 2D
system, we were able to detect approximately 275 individual
proteins spots on each gel. O3 exposure resulted in a signiﬁcant
change in the expression of 23 proteins as compared to FA control.
Table 1
Bronchoalveolar lavage cell differential analysis.
Filtered air Ozone p value
Volume recovered (mL) 6.5470.52 6.2370.48 0.32
% Yield 7377.00 6977.00 0.32
Cell counta
Macrophages 99.270.76 97.571.95 0.10
Neutrophils 1.3071.37 2.2070.68 0.75
Lymphocytes 0.3370.82 0.4271.90 0.23
Basophils 0.0070.00 0.1770.40 0.34
Lavage ﬂuid was recovered as described in Methods.
a Cell counts were generated using the average of 3 independent counts of 100
total cells/count and are represented as a percentage of total counted cells.
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Of these 23 proteins, mass spectrometry analyses identiﬁed 10
proteins. A master map showing the location of the identiﬁed
proteins and their assigned spot numbers is provided in Fig. 1A.
A comparison of the protein densities of these 10 proteins is shown
graphically in Fig. 1B. Unique protein identiﬁcations with statistical
analysis (% change and p values) and mass spectrometry details are
provided in Table 2. Each protein spot shown in the master map
matched the expected molecular weight and isoelectric point of
each identiﬁed protein (Table 2). Total protein density from 2D gels
is presented in Fig. 1C and shows that changes in individual protein
density were not due to differences in total protein loading of gels.
The 10 identiﬁed proteins were categorized into 4 broad groups:
cytoskeletal, energy metabolism, drug metabolism, and protein
folding/ER stress (Table 3).
Protein folding/ER stress proteins
Two proteins involved in ER stress were increased by O3
exposure. Protein disulﬁde isomerase (PDI) increased by 32% and
glucose-regulated protein 78 (GRP78) increased by 52% in liver of
O3 exposed rats compared to protein levels measured in FA
controls. PDI assists in the proper folding and disulﬁde bond
formation of proteins within the ER [24]. GRP78, a chaperone
protein located in the ER, plays an important role in the regulation
of the unfolded protein response activated during ER stress [25].
Drug metabolism proteins
Proteins that demonstrated signiﬁcant expression changes due to
O3 exposure compared to FA control samples included microsomal
cytochrome b5, catechol-O-methyltransferase (COMT), and glu-
tathione-S-transferase mu 1 (GSTM 1). Cytochrome b5 increased in
expression by 43% in liver of O3 exposed rats compared to FA
controls. This protein is important for CYP450 enzymatic reactions
involving fatty acid desaturation, metabolism of xenobiotics, and
cholesterol synthesis and breakdown [26]. COMT protein, a highly
abundant liver protein, increased by 50% in liver of O3 exposed rats.
COMT catalyzes O-methylation of catechol containing molecules [27]
and has been implicated in pathologies such as vascular disease and
Parkinson's disease due to the generation of reactive catecholamine
semiquinone species [28]. GSTM 1 decreased in expression by 27% in
liver of O3 exposed rats compared to FA controls. GSTM 1 is a phase II
xenobiotic metabolism enzyme responsible for the conjugation of
glutathione groups to endogenous and exogenous compounds for
excretion [29]. This enzyme is largely considered a hepatoprotective
enzyme due to its ability to conjugate reactive metabolites produced
as byproducts from oxidative stress mechanisms [29].
Energy metabolism and cytoskeletal proteins
Three proteins involved in energy metabolism, galactokinase,
glycerol kinase, and β-hydroxybutyrate dehydrogenase 1 (BDH1)
were increased by O3 exposure. Both galactokinase and glycerol
kinase increased in expression by 41% and 30%, respectively, in
response to O3, whereas BDH signiﬁcantly decreased in expression
by 32% in liver of O3 exposed rats compared to FA controls. BDH1 is
a mitochondrial protein that catalyzes the ﬁrst step of ketone body
metabolism, converting β-hydroxybutyrate to acetoacetate [30].
Cytoskeletal proteins that signiﬁcantly increased in response to O3
exposure were β-actin and α-tubulin, which are involved in cell
cycle, division, and motility [31].
Effect of O3 exposure on CYP450 and HO-1 protein levels
Previous studies showed that high O3 exposure levels (1–3 ppm)
prolonged pentobarbital-induced sleeping times in rodents,
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Fig. 1. Master map of liver proteins differentially altered by inhaled O3. Rats were exposed to ﬁltered air (FA) or O3 (0.5 ppm) for 8 h/day for 5 days. After exposures, livers
were removed and the post-nuclear supernatant was analyzed for global protein expression using 2D gel proteomics and mass spectrometry techniques. (A) Shows the
representative 2D gels of proteins from liver of FA and O3 exposed rats. Note that the circled protein “spots” were identiﬁed and are listed in Table 2 with respective p values.
(B) Shows the change in abundance (increase or decrease) of liver proteins found to be altered by inhaled O3. The number below each pair of bar graphs corresponds to the
protein spot shown in the master map (panel A) and match numbers used in Table 2. (C) Total protein density calculated from 2D gels generated from FA and O3 groups.
This result shows equal protein loading across all gels (p40.05). Data represent mean7SD of n¼6 animals per group.
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suggesting a decrease in xenobiotic metabolism [13,32]. Herein,
protein levels of CYP2E1 and 2B were measured to determine if
lower, more environmentally relevant exposures of O3 (0.5 ppm)
altered key drug metabolizing enzymes. After 5 days of 0.5 ppm O3
exposure, protein expression levels of CYP2E1 or CYP2B were not
signiﬁcantly changed as compared to FA controls (Fig. 2B and C).
Additionally, the stress inducible form of heme oxygenase, HO-1,
was measured in this study. Analysis showed no signiﬁcant differ-
ence in HO-1 protein levels between FA and O3 groups at the end of
5 exposure periods (Fig. 2A).
Discussion
A new disease paradigm has emerged in the ﬁeld of environ-
mental health sciences suggesting that inhalation of environmen-
tal pollutants, like O3, can exacerbate diseases that extend beyond
the pulmonary system; the initial site of exposure. Importantly, O3
inhalation may initiate a cascade of events leading to tissue
perturbations in other organ systems, including cardiovascular,
hematopoietic, and hepatic systems. In support of this new
concept, particulate matter (PM) and other gaseous pollutants
generated from industry and diesel exhaust exacerbate not only
pulmonary injury, but also cardiovascular disease [6]. Epidemio-
logical studies also report increased cardiovascular risk from high
ambient O3 days with signiﬁcant changes in blood lipids, blood
pressure, and factors important for glucose metabolism [8]. While
human exposures to inhaled pollutants typically involve hetero-
geneous mixtures of PM and O3, animal studies show that O3 alone
can damage cardiovascular tissues and cause hepatic changes
[10,14]. Importantly, in nonhuman primates exposure to O3 also
induces cardiovascular injury [10] and induces long-term altera-
tions in immune function [5].
The molecular events responsible for O3 induced systemic
effects are poorly deﬁned. The reaction of O3 within the lung is
complex and results in the production of a diverse array of
biologically active products. O3 reacts with mono-unsaturated
fatty acids to produce multiple aldehyde and hydroxyhydroper-
oxide species, as well as small amounts of the Criegee ozonide
[33,34]. Studies by Murphy, White, and colleagues demonstrated
that the reaction of O3 with calf lung surfactant resulted in the
formation of biologically active oxidized phospholipid species that
reduced cell viability by both necrotic and apoptotic mechanisms
[35]. Moreover, Friedman and colleagues have demonstrated that
multiple lipid ozonation products activate cellular signaling path-
ways and induce inﬂammatory mediators [36].
As most air pollution episodes last several days, single event
exposures in experimental laboratory studies are not environmentally
relevant. Most exposures are also not continuous but occur for several
hours per day for several consecutive days. For these reasons, we
designed an O3 exposure model that encompassed these features;
i.e., 8 h per day for 5 consecutive days. Further, the exposure regimen
Table 2
Hepatic proteins signiﬁcantly altered in abundance as a result of 0.5 ppm O3 exposure: results from 2D IEF/SDS-PAGE and mass spectrometry.
Spot # Protein identiﬁcation Mass (kDa) Isoelectric point (pI) % Change p value MOWSE score Peptides matched
1 Cytochrome b5 type A (microsomal) 11.4 5.26 41.6 0.038 166 6
2 Catechol-O-methyltransferase 29.8 5.41 50.9 0.025 132 5
3 Galactokinase 1 42.8 5.24 29.7 0.036 286 8
4 Actin, beta like 2 42.2 5.30 20.6 0.014 277 13
5 Protein disulﬁde-isomerase 57.3 4.82 32.3 0.002 784 34
6 Tubulin, alpha 1C 50.6 4.96 41.1 0.003 336 16
7 Glucose-regulated protein 78 72.5 5.07 52.0 0.002 467 15
8 Glycerol kinase 58.2 5.49 40.6 0.01 220 7
9 Glutathione S-transferase mu 1 25.8 8.27 27.5 0.021 350 15
10 D-β-hydroxybutyrate dehydrogenase, type I 38.7 8.93 31.6 0.033 187 8
Proteins identiﬁed as signiﬁcantly altered were matched to all Filtered Air (FA) and Ozone (O3) 2D IEF/SDS-PAGE gels. Spot # is the same number used to identify circled
proteins in Fig. 1A and densities shown in Fig. 1B. Data represent p values determined using a Student's unpaired t-test (two-tail).
Table 3
Description of cellular pathways and function of identiﬁed hepatic proteins altered O3 inhalation.
Protein
Identiﬁcation
Accession # Pathway Function
Cytochrome b5 GenBank:
AAB67609
Drug metabolism Cypb5 mediates the rate of P450 dependent mono-oxygenation reactions through the transfer of the
second electron from NADPH.
Catechol-O-
methyltransferase
GenBank:
NP_036663
Drug metabolism/L-
dopa metabolism
COMT enzymatically O-methylates catechol containing compounds. Both over expression and loss of
activity has been implicated in vascular diseases as well as neuronal disorders.
Galactokinase 1 GenBank:
NP_001008283
Cell cycle, energy
metabolism
First enzyme required for the conversion of galactose to glucose forming galactose-1-phosphate.
Actin, beta like 2 GenBank:
NP_001099879
Cytoskeletal Important for cell motility, structure, and integrity.
Protein disulﬁde-
isomerase
GenBank:
NP_037130
Protein Folding/ER
stress
PDI is responsible for inter and intra molecular disulﬁde bond formation within the endoplasmic
reticulum.
Tubulin, alpha 1C GenBank:
NP_001011995
Cytoskeletal Alpha tubulin is one of two components of tubulin which is assembled to form microtubules. These are
important for cell movement and maintenance of shape.
Glucose-regulated
protein 78
GenBank:
NP_037215
Protein Folding/ER
stress
Located within the ER; GRP78/BiP binds and inactivates the proteins responsible for UPR activation.
Also directly binds misfolded proteins to assist in proper folding or clearance.
Glycerol kinase GenBank:
NP_077357
Energy metabolism Catalyzes formation of glycerol 3-phosphate. Overexpression in H4IIE cells resulted in increased fat
storage and alters activity of PPAR-alpha and other transcription factors.
Glutathione
S-transferase mu 1
GenBank:
AAA41286
Phase II drug
metabolism
Facilitates conjugation of reduced glutathione to electrophilic compounds for increased excretion.
D-β-hydroxybutyrate
dehydrogenase
GenBank:
AAB59684
Energy/lipid
metabolism
Oxidoreductase, mitochondrial. Involved in fatty acid catabolism. BDH1 facilitates formation of the
ketone body 3-hydroxybutyrate.
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used in our current study better replicates a typical day where
ambient O3 concentrations have increased beyond the current NAAQS
standard of 0.075 ppm. The concentration of O3 used in the current
study is 0.5 ppm, which is higher than the NAAQS standard. Notably,
most experimental animal studies use O3 concentrations in the 0.8–
3.0 ppm range to examine health impacts. Higher doses of O3 are used
in experimental studies for a variety of reasons [11]. First, it is generally
accepted that because rats are obligate nose breathers and that they
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Fig. 2. Protein levels of HO-1, CYP2E1, and CYP2B in liver of O3 and FA rats. Rats were exposed to ﬁltered air (FA) or O3 (0.5 ppm) for 8 h/day for 5 days. After exposures, livers
were removed and homogenates were analyzed via western blot technique for (A) HO-1, (B) CYP2E1, (C) CYP2B, and (D) GAPDH as a loading control. O3 exposure did not
signiﬁcantly alter protein expression for all 4 proteins measured (p40.05). Full-size images of western blots were cropped to highlight protein bands of interest. Continuous
gel images are shown with approximate molecular weights provided next to blot image. Data represent mean7SD for n¼6 animals per group. HO-1, heme oxygenase-1;
CYP2E1, cytochrome P450 2E1; CYP2B, cytochrome P450 2B; and GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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have a more complex nasopharyngeal architecture that facilitates
removal of inhaled reactive gases; concentrations above those encoun-
tered by humans during typical ambient exposures should be
employed. Second, O3 exposures with animals are typically done
during the day when rats are less active/asleep (i.e., the light period
of a 12 h light:12 h dark cycle). Consequently, the combination of nose
breathing and low physical activity function to reduce the dose
delivered to the lower respiratory track of rats. These factors will
ultimately result in a lower composite dose of O3 reaching the lungs in
experimental animals as compared to typical human O3 exposures.
Following a 5 day O3 exposure protocol, we did not observe any
signiﬁcant changes to overall protein levels or inﬂammatory cells
within BALF extracted from lungs (Table 1). Increased protein in
BALF would indicate signiﬁcant epithelial damage and loss of
barrier integrity. It has been shown that repeated O3 exposures
increase neutrophils, lymphocytes, and macrophages in the lungs.
In rodents, neutrophilic inﬂammation generally begins to resolve
by day 3 following a 1.0 ppm O3 exposure [37]. We also did not
detect changes in plasma levels of ALT or AST enzyme activities;
common measurements for hepatocyte necrosis. Taken together,
these ﬁndings indicate that by the 5th day of O3 exposure, injury
may have resolved sufﬁciently to reduce injury metrics below
detectable levels. Similarly, we observed no change in CYP2E1 and
2B protein levels following O3 exposure, which supports recent
results showing no change in gene expression for these two
CYP450 enzymes following inhaled O3 exposure [14]. In addition
to looking at CYP450s, we measured expression of another key
stress responsive protein HO-1; the inducible member of the
heme-oxygenase enzyme family. Herein, we saw no change in
HO-1 protein after a 5 day O3 exposure regimen. The absence of
any change in HO-1 expression could be anticipated considering
HO-1 up-regulation typically occurs very early in response to
stress. Further, it is important to note that we measured HO-1
levels only at one time point. If O3 exposure elicited an early
hepatic stress response (e.g., HO-1 induction) at any time before
5 days it would have been missed in this study.
Despite the absence of overt lung and liver toxicity at Day 5,
O3 exposure did alter the levels of other key proteins in the liver as
evidenced by our proteomics analyses. Considering that only a
few studies have investigated the effects of inhaled O3 on the liver
[13–15] we took a global proteomic approach to determine
whether O3 exposure alters expression of liver proteins. Moreover,
we propose that investigating biological events and/or alterations
that occur after pulmonary inﬂammation has resolved is a more
relevant question for understanding human health impacts from
inhaled pollutants. Speciﬁcally, it is more important to determine
whether systemic alterations and/or pathological events induced
by O3 are still obvious after pulmonary inﬂammation has resolved
versus simply looking at downstream systemic sequelae that occur
at the same time as the toxic insult.
Using 2D gel electrophoresis techniques and mass spectro-
metry we detected over 20, and successfully identiﬁed 10, proteins
that were signiﬁcantly altered by O3 inhalation. These proteins
were grouped into 4 different categories: cytoskeletal, drug
metabolism, energy metabolism, and ER stress-related proteins;
with 8 proteins signiﬁcantly increased and 2 decreased in
response to inhaled O3 exposure. Two of the most intriguing
changes observed from our mass spectrometry data are the
increases in PDI and GRP78. Both proteins are located in the
endoplasmic reticulum and are involved in the proper folding of
proteins and maintenance of ER homeostasis. The ER is a complex
intracellular membranous network acting as the site for proper
folding and maturation of newly synthesized proteins. It is also
sensitive to a variety of signals and tightly regulated in order to
maintain proper protein and lipid homeostasis. One such signal is
excess accumulation of misfolded proteins, which activates the
unfolded protein response (UPR). GRP78 binds all three proteins
responsible for the activation of UPR (IRE1α, ATF6, and PERK),
rendering the signaling pathway inactive [24]. GRP78 is believed
to be released from the previous three proteins responsible for
UPR activation and is sequestered in the ER lumen where it binds
misfolded proteins and subsequently the UPR is activated [38].
An upregulation of GRP78 suggests that a mild form of ER stress
occurred by the Day 5 time point in order to bring the ER lumen
back to homeostasis. Indeed, overexpression of GRP78 protects
cells from known stressors such as a high fat diet; alleviating
injury and promoting restoration of ER homeostasis [39,40].
Additionally, studies investigating the effect of PM exposure show
induction of ER stress pathways in the liver of animal models with
pre-existing liver disease [41].
Despite no detectable effects on CYP2E1 and 2B protein levels we
did observe changes in other drug metabolism enzymes. We saw a
50% increase in COMT protein levels. COMT, a phase II drug metabo-
lism enzyme, O-methylates catechol-containing compounds including
dietary phytochemicals and metabolites of toxic aryl hydrocarbons
[28]. Increases in COMT may be a protec-
tive adaptive response because accumulation of endogenous catecho-
lamines can spontaneously or enzymatically be converted to semi-
quinone and quinone intermediates that are cytotoxic [28,42]. In
contrast, we saw a decrease in liver GSTM 1 in response to O3
exposure. The GST super-family consists of phase II drug metabolism
enzymes and GSTM 1 is one of seven GST M isoforms [29]. Substrates
for GSTs include environmental chemicals, like acrolein and DDT, as
well as, numerous drugs and endogenous reactive lipid species [43].
Conjugation of GSH with these compounds typically produces less
reactive products that are subsequently excreted; thus, ameliorating
cellular oxidative stress and toxicity. GST enzymes are typically
increased in response to stress and considered a conserved adaptive
response as it occurs throughout the animal kingdom [44]. Interest-
ingly, we observed that hepatic GSTM 1 protein was signiﬁcantly
decreased by O3 inhalation. While several studies have reported that
the GSTM 1 deﬁciency is associated with decreased lung function and
airway inﬂammation following O3 exposure [45]; the impact of O3 and
GSTM 1 deﬁciency on the liver is not known. Animal models null for
GSTM 1 display altered hepatic drug clearance [46]. In the context of
the current study, decreased GSTM 1 protein in the liver after O3
inhalation could impair adaptive stress responses and/or impair
hepatic drug metabolism and clearance mechanisms. Importantly, this
could manifest as a serious problem in individuals with GSTM
1 polymorphisms exposed to O3. Indeed, individuals with the GSTM
1 null polymorphism are at higher risk for hepatocellular carcinoma,
alcoholic liver disease, and obesity associated fatty liver disease [47–
50]. A proteomic analysis of alcohol-induced liver injury found that
chronic, binge ethanol administration decreased GSTM 1 levels in liver
[51]. Therefore, the failure of key adaptive stress responses may be
critical in how liver responds and adapts to O3 [52]. Finally, β-actin and
α-tubulin, were found to be altered by O3. Adduction of these proteins
by reactive lipid species and acetaldehyde disrupts the cytoskeletal
network in hepatocytes [31] with increases in transcript and protein
observed in an animal model of pancreatic injury [53].
It was postulated that these increases play a protective role by
increasing the amount of cytoskeletal protein needed to replace
damaged or modiﬁed β-actin and α-tubulin in the cell. Taken together,
these results suggest that inhaled O3 alters protein expression patterns
in an organ (liver) distal from initial site of exposure.
Conclusion
In summary, we report that an environmentally-relevant inha-
lation exposure to O3 alters the liver proteome. We observed
signiﬁcant changes in the expression of key stress response and
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drug metabolism proteins in the liver following O3 inhalation.
While it is well established that O3 can exacerbate pulmonary
diseases, an emerging literature indicates that inhaled O3 may
have signiﬁcant effects on other organ systems, including the liver.
Thus, it will be important to better understand how these systemic
effects could impact health. Importantly, the systemic effects
observed with O3 alone may be exacerbated when coupled to
pre-existing diseases and pathologies. For example, animals pre-
disposed to heart disease display greater vascular injury when
exposed to O3 [10]. In addition, rodents administered acetamino-
phen, a known hepatotoxicant, have increased liver injury follow-
ing O3 exposure [54]. Also, genetic predisposition to obesity in
multiple animal models modulates airway hypersensitivity and
inﬂammatory cytokines as compared to unexposed obese controls
[55–57]. Together, the results from the current study provides new
insight into the growing ﬁeld of environmental-related disease
and health impacts from inhaled pollutants and suggest that the
liver is a systemic site impacted by O3.
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